AbbVie Demonstrates Commitment to Continued Research in Hepatitis C with Investigational Data from Clinical Program Being Presented at The Liver Meeting®
Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for FDA Review
The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol
Data From Phase 3 RUTHERFORD-2 Study Show Evolocumab Significantly Reduced Mean LDL-C by 59-66 Percent Compared to Placebo in Patients With Heterozygous Familial Hypercholesterolemia
Legal Settlement, Data Presentation, Welfare Initiatives, Acquisition Talks, and Study Results - Research Reports on Shire, Merck, Medtronic, Salix and Johnson & Johnson
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, October 1, 2014
ABBOTT PARK, Ill., Oct.
Amgen Announces Moderate-To-Severe Plaque Psoriasis Data To Be Presented At The 23rd Congress Of The European Academy Of Dermatology And Venereology
Featured Presentations Highlight Data From Approved and Investigational Agents Across Amgen's Dermatology Portfolio
THOUSAND OAKS, Calif.
Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance
Acquisition Strengthens Existing Pipeline in Viral Diseases
NEW BRUNSWICK, N.J., Sept.
Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market
Ventana is committed to accelerating the discovery and development of new cancer diagnostic tests that help determine the best course of therapy for each individual patient.
Prospects For Leading Players
NEW YORK, Sept. 30, 2014 /PRNewswire/ -- Report Details
MSF URGES PRIME MINISTER MODI TO RESIST U.S. POLITICAL PRESSURE TO RESTRICT GLOBAL ACCESS TO MEDICINES
FDA Approves RELISTOR® Subcutaneous Injection for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-cancer Pain
INDIANAPOLIS, Sept. 29, 2014 /PRNewswire/ -- On Oct.
The Ohio State University Issues Purchase Order For Lab Supplies To NanoLogix